9-cis-Retinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed-type allergy

Contact Dermatitis

Volumn 78, Issue 1, 2018, Pages 41-54

  Kraus, Lea Franziska ^a   Scheurmann, Natalie ^a   Frenzel, Denis F ^a   Tasdogan, Alpaslan ^a   Weiss, Johannes M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

9 cis retinoic acid; contact hypersensitivity; dendritic cells; eczema; osteopontin; regulatory T cells; tolerance

Indexed keywords

ALITRETINOIN; CCL1 CHEMOKINE; CD28 ANTIGEN; CD3 ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; OSTEOPONTIN; RNA; ALPHA E INTEGRINS; ALPHA INTEGRIN; ANTINEOPLASTIC AGENT; CD207 PROTEIN, MOUSE; GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 2; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; MEMBRANE ANTIGEN; RETINOIC ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CONDITIONED MEDIUM; DELAYED HYPERSENSITIVITY; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; SKIN ALLERGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; CD11C ANTIGEN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; INTEGRIN ALPHA CHAINS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; OSTEOPONTIN; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRETINOIN;

EID: 85029229425     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12868     Document Type: Article

References (47)

1. Ruzicka T, Lynde C W, Jemec G B et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008: 158: 808–817.
2. Mora J R, Iwata M, von Andrian U H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008: 8: 685–698.
3. Kane M A. Analysis, occurrence, and function of 9-cis-retinoic acid. Biochim Biophys Acta 2012: 1821: 10–20.
4. Sun C M, Hall J A, Blank R B et al. Small intestine lamina propria dendritic cells promote denovo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007: 204: 1775–1785.
5. Honda T, Egawa G, Grabbe S, Kabashima K. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 2013: 133: 303–315.
6. Raker V K, Domogalla M P, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol 2015: 6: 569. doi: 10.3389/fimmu.2015.00569
7. Kimber I, Travis M A, Martin S F, Dearman R J. Immunoregulation of skin sensitization and regulatory T cells. Contact Dermatitis 2012: 67: 179–183.
8. Geissmann F, Revy P, Brousse N et al. Retinoids regulate survival and antigen presentation by immature dendritic cells. J Exp Med 2003: 198: 623–634.
9. Tomura M, Honda T, Tanizaki H et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 2010: 120: 883–893.
10. Josefowicz S Z, Lu L F, Rudensky A Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012: 30: 531–564.
11. Cantor H, Shinohara M L. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat Rev Immunol 2008: 9: 137–141.
12. Frenzel D F, Weiss J M. Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy. Expert Rev Clin Immunol 2011: 7: 93–109.
13. Seier A M, Renkl A C, Schulz G et al. Antigen-specific induction of osteopontin contributes to the chronification of allergic contact dermatitis. Am J Pathol 2010: 176: 246–258.
14. Renkl A C, Wussler J, Ahrens T et al. Osteopontin functionally activates dendritic cells and induces their differentiation towards a Th-1 polarizing phenotype. Blood 2005: 106: 946–955.
15. Salvi V, Scutera S, Rossi S et al. Dual regulation of osteopontin production by TLR stimulation in dendritic cells. J Leukoc Biol 2013: 94: 147–158.
16. Da Silva A P, Ellen R P, Sørensen E S et al. Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Invest 2009: 89: 1169–1181.
17. Da Silva A P, Pollett A, Rittling S R et al. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol 2006: 208: 629–639.
18. Liaw L, Birk D E, Ballas C B et al. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 1998: 101: 1468–1478.
19. Collison L W, Vignali D A. In vitro Treg suppression assays. Methods Mol Biol 2011: 707: 21–37.
20. Martin S F. Induction of contact hypersensitivity in the mouse model. Methods Mol Biol 2013: 961: 325–335.
21. Weiss J M, Renkl A C, Sleeman J et al. CD44 variant isoforms are essential for the function of epidermal Langerhans cells and dendritic cells. Cell Adhes Commun 1998: 6: 157–160.
22. Kryczanowsky F, Raker V, Graulich E et al. IL-10-modulated human dendritic cells for clinical use: identification of a stable and migratory subset with improved tolerogenic activity. J Immunol 2016: 197: 3607–3617.
23. Cassani B, Villablanca E J, De Calisto J et al. Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol Aspects Med 2012: 33: 63–76.
24. Scott C L, Aumeunier A M, Mowat A M. Intestinal CD103+ dendritic cells: master regulators of tolerance? Trends Immunol 2011: 32: 412–419.
25. Nestle F O, Di Meglio P, Qin J Z, Nickoloff B J. Skin immune sentinels in health and disease. Nat Rev Immunol 2009: 9: 679–691.
26. Kiss M, Czimmerer Z, Nagy L. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: from physiology to pathology. J Allergy Clin Immunol 2013: 132: 264–286.
27. Nagy L, Szanto A, Szatmari I, Szeles L. Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev 2012: 92: 739–789.
28. Manicassamy S, Ravindran R, Deng J et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 2009: 15: 401–409.
29. Villablanca E J, Zhou D, Valentinis B et al. Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo. J Leukoc Biol 2008: 84: 871–879.
30. Villablanca E J, Wang S, De Calisto J et al. MyD88 and retinoic acid signaling pathways interact to modulate gastrointestinal activities of dendritic cells. Gastroenterology 2011: 141: 176–185.
31. Hengesbach L M, Hoag K A. Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. J Nutr 2004: 134: 2653–2659.
32. Hall B M, Verma N D, Tran G T, Hodgkinson S J. Distinct regulatory CD4+T cell subsets; differences between naive and antigen specific T regulatory cells. Curr Opin Immunol 2011: 23: 641–647.
33. Hall J A, Grainger J R, Spencer S P, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity 2011: 35: 13–22.
34. Johansson-Lindbom B, Svensson M, Pabst O et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med 2005: 202: 1063–1073.
35. Kaplan D H, Igyarto B Z, Gaspari A A. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 2012: 12: 114–124.
36. Flacher V, Tripp C H, Mairhofer D G et al. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance. EMBO Mol Med 2014: 6: 1191–1204.
37. Gomez D A, Vocanson M, Hacini-Rachinel F et al. Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J Clin Invest 2012: 122: 1700–1711.
38. Liu J, Cao X. Regulatory dendritic cells in autoimmunity: a comprehensive review. J Autoimmun 2015: 63: 1–12.
39. Hill J A, Hall J A, Sun C M et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 2008: 29: 758–770.
40. Mucida D, Pino-Lagos K, Kim G et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 2009: 30: 471–472.
41. Xanthou G, Alissafi T, Semitekolou M et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007: 13: 570–578.
42. Rittling S R, Singh R. Osteopontin in immune-mediated diseases. J Dent Res 2015: 94: 1638–1645.
43. Steinman L. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 2009: 9: 440–447.
44. Inoue M, Shinohara M L. Intracellular osteopontin (iOPN) and immunity. Immunol Res 2011: 49: 160–172.
45. Leavenworth J W, Verbinnen B, Yin J et al. A p85alpha-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells. Nat Immunol 2015: 16: 96–106.
46. Sangaletti S, Tripodo C, Sandri S et al. Osteopontin shapes immune suppression in the metastatic niche. Cancer Res 2014: 74: 4706–4719.
47. Schindler M, Drozdenko G, Kuhl A A, Worm M. Immunomodulation in patients with chronic hand eczema treated with oral alitretinoin. Int Arch Allergy Immunol 2014: 165: 18–26.